RecruitingPulmonary Embolism

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Eligible age

18+ yrs

Accepts

All genders

Locations

24 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.

Sponsor: NYU Langone Health

You may qualify if…

✓ 1. Symptomatic PE diagnosed by contrast-enhanced CT angiography with involvement of a main or lobar pulmonary artery branch; and
✓ 2. Right ventricular (RV) dilation as defined by the presence of an RV/Left ventricular ratio \> 1 on CT angiography

You may not qualify if…

✕ 1. Age \< 18 years
✕ 2. Systolic blood pressure \< 90 mmHg for \>15 consecutive minutes or \> 40 mmHg drop from baseline, or vasopressor requirement for blood pressure support (i.e., massive PE), occurring within 1 hour prior to eligibility assessment.
✕ 3. Symptom duration \> 14 days for the current PE episode
✕ 4. Irreversible INR \> 3
✕ 5. Irreversible Thrombocytopenia (Platelets \< 50,000/microliter)
✕ 6. Creatinine \> 2.0 mg/dl
✕ 7. Hemoglobin \< 7.0 g/dl
✕ 8. Pregnancy (positive urine or blood pregnancy test (a pregnancy test must be obtained within 7 days prior to randomization in people of childbearing potential))